Tag: tripath imaging

February 24, 2014 “Intelligence: Late Breaking Lab News”

Maybe the tough financial environment here in the United States is causing Sonic Healthcare Ltd., one of this nation’s bigger lab players, to be more interested in overseas lab testing opportunities. On February 18, its CEO, Colin Goldschmidt, M.D., told investors that “We continue to seek out synergistic [laboratory] acquisitions and we believe that Germany

View Article

September 25, 2006 “Intelligence: Late Breaking Lab News”

On September 8, Becton, Dickinson & Company (BD) announced that it would acquire TriPath Imaging, Inc. for a purchase price of approximately $350 million. TriPath’s share price has not moved significantly over the past five years, so many shareholders were pushing for change. BD and TriPath have been close collaborators in several areas of molecular

View Article

September 5, 2006 “Intelligence: Late Breaking Lab News”

On August 14, AmeriPath, Inc. released its second quarter earnings report. Revenues were $191.7 million, an increase of 35% from $143.6 million posted in second quarter of 2005. These numbers reflect the acquisition of Specialty Laboratories, Inc., which AmeriPath acquired on January 31, 2006. (See TDR, October 3, 2005.) Quarterly revenues for Specialty Laboratories was

View Article

Genomic Health, TriPath Imaging, Bio-Reference Labs, Canadian Patient Registry

PREDICTIVE TESTING FOR RECURRENT BREAST CANCER
LABORATORY TESTS DESIGNED to predict the recurrence of breast cancer are picking up momentum. First to market was Genomic Health Inc.’s Oncotype DX™ breast cancer test. Now TriPath Imaging, Inc. is reporting favorable results from studies of its ProEx Br markers for breast cancer.

Since introducing Oncotype DX in 2004, Genomic

View Article